Mr. Stuart Breslin is the founder and President of Conversions Consulting LLC; a company focused on impactful medical device development. Over the last 10 years, Mr. Breslin has helped both small and large Pharma identify and develop novel technologies for the administration of their medicines.

Prior to consulting, Mr. Breslin worked for Eli Lilly and Company. Over a 34-year career, he had a variety of roles in Parenteral Products, Planning, Dry Products, Final Purification and finally 16 years in medical device development.

Under his guidance, Lilly's medical device group improved hoe people administered their medication with the development of a number of innovative technologies including HumaPen® Luxura™, HumaPen® Memoir™, Humalog® KwikPen™, HumaPen® Savvio™, and the autoinjectors for Trulicity®, Taltz®, Emgality®, Zepbound® and Monjaro®.